Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases
- PMID: 11596990
- DOI: 10.1016/s0065-2660(01)44086-7
Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases
Abstract
Multiple-option prenatal carrier testing in the Ashkenazi Jewish community for three and now eight disorders has been readily accepted in this prenatal, health-oriented and knowledgeable population. Counseling of screenees concerning the nature (severity, treatability, etc.), inheritance, and frequencies of each disorder was essential for informed test choices and future reproductive decision making. The value of couple testing for a group of disorders when 1 in about 6 would be found to be a carrier of at least one disease was emphasized. These studies identified issues of education, confidentiality, posttest anxiety, and self-esteem that must be continuously addressed in the Ashkenazi population. However, an important value of these studies is that they provide a framework for the development of mass carrier screening programs in the general population or in specific segments of the population with similar demographic characteristics and in more diverse prenatal populations.
Similar articles
-
Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.Hum Mutat. 2010 Nov;31(11):1240-50. doi: 10.1002/humu.21327. Hum Mutat. 2010. PMID: 20672374 Free PMC article.
-
Prenatal genetic screening in the Ashkenazi Jewish population.Clin Perinatol. 2001 Jun;28(2):367-82. doi: 10.1016/s0095-5108(05)70089-0. Clin Perinatol. 2001. PMID: 11499058 Review.
-
Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.Am J Obstet Gynecol. 2014 Sep;211(3):197-204. doi: 10.1016/j.ajog.2014.02.001. Epub 2014 Feb 5. Am J Obstet Gynecol. 2014. PMID: 24508465 Review.
-
Prenatal genetic carrier testing using triple disease screening.JAMA. 1997 Oct 15;278(15):1268-72. JAMA. 1997. PMID: 9333269
-
DNA-based carrier screening in the Ashkenazi Jewish population.Expert Rev Mol Diagn. 2004 May;4(3):377-92. doi: 10.1586/14737159.4.3.377. Expert Rev Mol Diagn. 2004. PMID: 15137904 Review.
Cited by
-
Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.Hum Mutat. 2010 Nov;31(11):1240-50. doi: 10.1002/humu.21327. Hum Mutat. 2010. PMID: 20672374 Free PMC article.
-
Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.J Mol Diagn. 2009 Nov;11(6):530-6. doi: 10.2353/jmoldx.2009.090050. Epub 2009 Oct 8. J Mol Diagn. 2009. PMID: 19815695 Free PMC article.
-
Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).BMC Med Genet. 2006 Aug 3;7:69. doi: 10.1186/1471-2350-7-69. BMC Med Genet. 2006. PMID: 16887033 Free PMC article.
-
Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.J Genet Couns. 2006 Feb;15(1):61-70. doi: 10.1007/s10897-005-9004-5. J Genet Couns. 2006. PMID: 16468087
-
Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screening.Genet Med. 2017 Jun;19(6):652-658. doi: 10.1038/gim.2016.159. Epub 2016 Oct 13. Genet Med. 2017. PMID: 27735925
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical